Commercial Eyes is delighted to announce that as of today, Dr Greg Pearce is our new Director, Regulatory Services. Greg has been with Commercial Eyes since 2013 as a Senior Regulatory Consultant and is a welcome addition to our leadership team.
Greg’s career in the pharmaceutical industry spans almost 30 years. As a pharmacist with a PhD in pharmacology, Greg has broad ranging experience in both operational and management positions across regulatory affairs, pharmacovigilance, medical affairs, the evaluation of scientific and technical documents, promotional review and health economics.
During his time at Commercial Eyes, Greg has been able to draw on his diverse experience – providing valuable technical support and commercialisation advice to our clients across the R&D based and generic prescription and OTC sectors.
He has a long held interest in the quality use of medicines and the pivotal role of evidence in informing and guiding the market entry process. Greg has particular experience in preparing literature based submissions, preparing non clinical and clinical summaries and alternative non trial approaches supporting generic applications.
Greg says, “I see Commercial Eyes as a broad based, highly experienced consultancy, which is uniquely placed to provide high quality, cost effective Regulatory Services in an increasingly demanding, differentiated and resource constrained market. I’m grateful to be supported across all areas of device, medicines and cosmetic regulation by our highly experienced and knowledgeable Regulatory Services team.”
Greg is based in our Sydney office and is looking forward to his new role.